A Study Of Cisplatin (Or Carboplatin) And Etoposide With Or Without Figitumumab (CP-751,871) In Patients With Extensive-Stage Small Cell Lung Cancer

NCT00977561 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

9

Enrollment

INDUSTRY

Sponsor class

Stopped See termination reason in detailed description.

Conditions

Small Cell Lung Carcinoma

Interventions

DRUG: figitumumab
DRUG: Cisplatin (Or Carboplatin)
DRUG: Etoposide
DRUG: Cisplatin (Or Carboplatin)
DRUG: Etoposide

Sponsor

Pfizer